Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Assicurazioni Generali SpA

Start price
Target price
Perf. (%)
€18.93
05.09.23
-
05.09.24
26.04%
02.06.24

buy
AXA S.A.

Start price
Target price
Perf. (%)
€27.70
05.09.23
-
05.09.24
21.16%
02.06.24

buy
Allianz SE VNA

Start price
Target price
Perf. (%)
€222.85
05.09.23
-
05.09.24
11.04%
31.01.24

Standard Chartered plc

Start price
Target price
Perf. (%)
€8.36
04.09.23
-
04.09.24
9.00%
13.08.24

The Howard Hughes Corp.

Start price
Target price
Perf. (%)
€71.00
04.09.23
-
04.09.24
-
11.08.23

buy
Fiserv Inc.

Start price
Target price
Perf. (%)
€113.50
04.09.23
-
04.09.24
33.00%
21.08.24

buy
Gaia Inc. A

Start price
Target price
Perf. (%)
€2.24
04.09.23
-
04.09.24
52.68%
21.08.24

Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.23
04.09.23
-
04.09.24
15.65%
05.01.24

buy
Key Tronic Corp.

Start price
Target price
Perf. (%)
€4.38
04.09.23
-
04.09.24
-12.79%
21.08.24

T2 Biosystems Inc.

Start price
Target price
Perf. (%)
€0.34
04.09.23
-
04.09.24
-51.40%
20.11.23

Novan Inc

Start price
Target price
Perf. (%)
€0.018
04.09.23
-
04.09.24
-94.29%
19.09.23

Tellurian Inc

Start price
Target price
Perf. (%)
€1.06
04.09.23
-
04.09.24
-51.85%
19.01.24

Probably not worthwhile Investment
buy
AC Immune Ltd

Start price
Target price
Perf. (%)
€3.25
04.09.23
-
04.09.24
7.86%
11.12.23

Could be worthwhile Investment >10% per year
First Hydrogen Corp.

Start price
Target price
Perf. (%)
€1.72
04.09.23
€0.000
04.09.24
-19.03%
05.11.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
overvalued
buy
Kopin Corp.

Start price
Target price
Perf. (%)
€1.31
04.09.23
€4.00
04.09.24
-3.97%
04.11.23

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Probably not worthwhile Investment
buy
Blue Apron Holdings Inc.

Start price
Target price
Perf. (%)
€7.70
04.09.23
€15.60
04.09.24
-27.27%
18.09.23

Could be very worthwhile Investment >20% year
buy
Endeavour Silver Corp.

Start price
Target price
Perf. (%)
€2.55
04.09.23
-
04.09.26
22.02%
15.05.24

Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
EBIT growth > 30% per year expected
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€1.97
03.09.23
-
03.09.24
-21.32%
13.09.23

Risky Investment
buy
Fannie Mae (Federal National Mortgage Association)

Start price
Target price
Perf. (%)
€0.56
03.09.23
€2.00
03.09.24
109.01%
21.08.24

EBIT growth > 30% per year expected
Very differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Standard Investments for future growth
buy
Axon Enterprise INC

Start price
Target price
Perf. (%)
€200.50
03.09.23
€230.00
31.07.25
6.98%
02.12.23

Could be very worthwhile Investment >20% year
buy
AEHR Test Systems

Start price
Target price
Perf. (%)
€48.70
03.09.23
€60.00
30.09.25
-54.17%
02.12.23

Could be very worthwhile Investment >20% year
buy
Builders Firstsource

Start price
Target price
Perf. (%)
€138.35
03.09.23
€200.00
30.11.25
-5.49%
02.12.23

Could be very worthwhile Investment >20% year
buy
Ocuphire Pharma Inc.

Start price
Target price
Perf. (%)
€3.71
03.09.23
€5.00
30.11.25
-68.10%
20.08.24

Could be very worthwhile Investment >20% year
buy
Crinetics Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€16.20
03.09.23
€20.00
30.11.25
75.31%
01.10.23

Could be very worthwhile Investment >20% year
buy
Adobe Inc.

Start price
Target price
Perf. (%)
€523.60
03.09.23
€650.00
30.09.25
6.99%
02.12.23

Could be very worthwhile Investment >20% year